Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
OREX (NASDAQ: OREX)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Four Senior Executives Join Orexigen(R) Therapeutics Management Team
Nov 23, 2009 08:02 AM |
OREX
Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
Nov 12, 2009 08:02 AM |
OREX
Canaccord Capital Inc. présente ses résultats du deuxième trimestre de 2010
Nov 05, 2009 06:02 AM |
CCI
,
GMCR
,
OREX
,
ZINC
Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
Nov 04, 2009 04:02 PM |
OREX
Orexigen(R) Therapeutics Schedules November 4, 2009 Webcast Discussion of Financial Results for the Third Quarter Ended September 30, 2009
Oct 29, 2009 04:01 PM |
OREX
Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
Oct 27, 2009 11:20 AM |
OREX
Orexigen(R) Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk
Oct 24, 2009 01:00 PM |
OREX
Orexigen(R) Therapeutics Announces Contrave(R) Data Presentations at Annual Scientific Meeting of The Obesity Society
Oct 21, 2009 08:02 AM |
OREX
FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 13, 2009 12:34 PM |
ACCP
,
APOL
,
CLDA
,
CRI
,
CRL
,
CYTX
Orexigen(R) Therapeutics to Speak at JMP Securities Healthcare Focus Conference
Oct 01, 2009 08:02 AM |
OREX
More..
Canaccord Capital Inc. reports fiscal second quarter 2010 results
Nov 05, 2009 06:52 AM |
OREX
,
ZINC
Domain Raises $500M Life Sciences Fund
Aug 11, 2009 03:57 PM |
AMLN
,
CADX
,
OREX
,
SNTS
,
VOLC
Orexigen Therapeutics Prices Public Offer at $7.50
Jul 24, 2009 12:05 PM |
OREX
Orexigen Therapeutics Posts Loss
Mar 12, 2009 04:19 PM |
OREX
More..
Orexigen Therapeutics Closed for 17.5% Gain By Galtstock Subscribers!
Oct 09, 2009 01:14 PM |
BAC
,
OREX
,
POT
,
UPL
Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer
Aug 24, 2009 08:02 AM |
OREX
Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
Aug 06, 2009 04:01 PM |
OREX
Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference
Aug 05, 2009 04:01 PM |
OREX
Orexigen(R) Therapeutics Schedules August 6, 2009 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2009
Aug 04, 2009 04:02 PM |
OREX
Biotech Hot in July Driven By Positive Drug Data and Acquisitions
Aug 03, 2009 01:14 PM |
EPIX
,
FRX
,
HGSI
,
OREX
Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters
Jul 24, 2009 04:01 PM |
OREX
StockPreacher.com Issues Trading Outlook for Orexigen Therapeutics Inc.
Jul 24, 2009 06:50 AM |
ARNA
,
ATHX
,
CYPB
,
OREX
,
VVUS
Orexigen(R) Therapeutics Prices Public Offering of Common Stock
Jul 23, 2009 08:56 AM |
OREX
Orexigen(R) Therapeutics Announces Proposed Public Offering of Common Stock
Jul 22, 2009 04:02 PM |
OREX
More..
Form 4 Orexigen Therapeutics, For: Nov 16 Filed by: DUNAYEVICH EDUARDO (10K)
Nov 18, 2009 07:30 PM
Form 4 Orexigen Therapeutics, For: Nov 12 Filed by: VITULLO NICOLE (10K)
Nov 16, 2009 03:32 PM
Form 4 Orexigen Therapeutics, For: Nov 12 Filed by: Halak Brian K (10K)
Nov 16, 2009 03:27 PM
Form 4 Orexigen Therapeutics, For: Nov 12 Filed by: SCHOEMAKER KATHLEEN K (10K)
Nov 16, 2009 03:25 PM
Form 4 Orexigen Therapeutics, For: Nov 12 Filed by: TREU JESSE I (10K)
Nov 16, 2009 03:21 PM
Form 4 Orexigen Therapeutics, For: Nov 12 Filed by: DOVEY BRIAN H (10K)
Nov 16, 2009 03:17 PM
Form 4 Orexigen Therapeutics, For: Nov 12 Filed by: BLAIR JAMES C (10K)
Nov 16, 2009 03:14 PM
Form 4 Orexigen Therapeutics, For: Nov 12 Filed by: DOMAIN PARTERS VII L P (10K)
Nov 16, 2009 03:07 PM
Form 4 Orexigen Therapeutics, For: Nov 10 Filed by: VITULLO NICOLE (10K)
Nov 12, 2009 05:27 PM
Form 4 Orexigen Therapeutics, For: Nov 10 Filed by: Halak Brian K (10K)
Nov 12, 2009 05:25 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
OREX
Compare to S&P
YTD
23.12 %
1.90 %
4 Weeks
-10.20 %
-11.16 %
12 Weeks
-15.50 %
-20.33 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
35.29 %
EPS Growth in Last Year:
54.17 %
Sales Growth in Last Quarter:
0.00 %
Sales Growth in Last Quarter:
0.00 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
